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Abstract
Protozoan parasites cause some of the world’s most important diseases. Genome
sequencing information is rapidly being acquired and combined with new developments in
functional genome analysis to transform our understanding of parasites, and to enable new
approaches to combating the diseases they cause. Copyright # 2001 John Wiley & Sons,
Ltd.
Keywords: parasite; functional genomics; protozoa; apicomplexa; plasmodium; trypano-
soma; leishmania
Introduction
To facilitate the dissemination of the exciting new
data, a public discussion meeting, hosted by The
Royal Society, was organised by Professor Jennie
Blackwell, Professor Chris Newbold, Dr Mike Turner
and Professor Keith Vickerman FRS. The aim was to
provide an opportunity for researchers working on
many different parasites to discuss and co-ordinate
their functional genomics approaches in the light of
the wealth of sequence data emerging from the
genome centres. Since the Plasmodium falciparum
(malaria) genome project was initiated in 1996, a
broad range of other parasite genomes are now being
sequenced, resulting in a sea change in the way that
parasite biology can be investigated. The discussion
meeting was spilt into four half-day sessions; this
report covers a cross-section of the papers presented
to an audience of over 270 delegates. A full list of
presentations is provided in Table 1.
Presentations
To provide an example framework for how
sequence data can be effectively utilised for func-
tional genomics approaches to cell biology, Steve
Oliver (Manchester, UK) reported on the experience
of the yeast community, who obtained their
complete genome sequence back in 1995. In his
paper ‘Functional genomics: lessons from yeast’ he
suggested one of the lessons for the parasite
community is that much can be achieved when the
community works together, whether this was in the
area of genome, transcriptome, proteome, or
metabolome. The yeast community saw global
expression analysis and high-throughput gene
knockouts as a pre-competitive resource. As the
annotated yeast genome sequence preceded the
development and application of DNA microarray
technologies, the community had collaborated in
high-throughput northern analysis on all of the
yeast genes; genome-wide knockouts were also done
as part of a community-wide collaborative endea-
vour. Laboratories acting independently could
never have contemplated this work. It was encoura-
ging that this model of ‘community research’ had
been adopted for the parasite sequencing projects,
and was now being applied more and more to
protozoan functional genomics approaches. This
has been considerably encouraged by the funding
agencies, whose policies are increasingly emphasis-
ing the importance of multidisciplinary/centre col-
laborations to answer biological questions.
Jennie Blackwell’s (Cambridge, UK) presentation
‘From genomes to vaccines – Leishmania as a model’
Comparative and Functional Genomics
Comp Funct Genom 2001; 2: 257–262.
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microarray technology as a means of assessing
gene function. The aim of the work is to identify
genes that are expressed in the metacyclic promas-
tigote and amastigote forms of the parasite. It is the
metacyclic stage promastigote that invades and
survives as an amastigote form in the mammalian
host; hence genes expressed at these stages of the
life cycle provide possible targets for vaccines.
Fortunately, the majority of the life-cycle stages of
Leishmania major can be mimicked in vitro, and
RNA proﬁles can thus be obtained for a wide range
of deﬁned developmental points of the life cycle.
Initial proﬁling studies (using EST-based datasets)
have been conducted with arrays comprising
approximately 1000 of the estimated 8000 Leishma-
nia genes; as the proportion of the genome
sequenced increases, this work will be extended to
all predicted genes of Leishmania major. It was clear
from the analyses performed so far that clustering
of expression proﬁles (using the EPCLUST soft-
ware package developed by Jaak Vilo at the
European Bioinformatics Institute) could identify
several genes whose expression characteristics were
worthy of conﬁrmation by Northern analysis and
further study in vitro and in vivo.
One observation, also noted by a number of
researchers including Steve Oliver, working on
yeast, and Steve Beverley, who reported on his
genome survey sequence (GSS) microarray studies
in Leishmania, was that small conceptual or
practical errors in performing microarray experi-
ments frequently lead to misleading results. All
stressed the paramount importance of standardisa-
tion of assay conditions, particularly if data
obtained from different laboratories/experiments
were ever to be compared.
Blackwell’s group are also piloting the use of
DNA vaccines in mice as a possible high-
throughput tool for identifying new vaccine targets.
Initially, this was performed using cDNAs that are
thought to be either predominantly, or exclusively,
expressed in the amastigote stage of the parasite.
Initial experiments were conducted using a pooling
strategy, but when single DNA samples from
potentially ‘protective’ pools were used, different
results were obtained; DNA vaccines are now being
screened individually.
Dan Carucci (Naval Medical Research Center,
USA) spoke on ‘Technologies for the study of gene
and protein expression in Plasmodium’. He intro-
duced some of the new techniques that are available
to analyse the genomes, transcriptomes and pro-
teomes of parasites. These technologies are being
utilised by The Naval Medical Research Center to
develop potential vaccines for the malaria parasite
Plasmodium falciparum.
The Carucci lab has now made microarray DNA
chips for chromosomes 2, 3, 12 and 14 of
P. falciparum and they plan to extend this to the
entire malaria genome over the next two years.
These microarrays can be used to study effects of
drugs on parasite growth, mechanisms of drug
resistance, mechanisms of antigenic variation and
genes involved in cell invasion. However, Carucci
stressed that for these experiments to be mean-
ingful, numerous replicate experiments must be
carried out and that changes in expression levels
need to be shown to be statistically signiﬁcant.
While microarrays can give a good indication of
gene expression proﬁles within the cell, this does not
necessarily provide a measure of protein dynamics.
The Carucci lab is using high-throughput proteo-
mics to study the protein content of parasite cells.
The traditional workhorse of proteomics, the 2D
gel, is cumbersome, can be difﬁcult to reproduce
reliably, and only displays soluble proteins; hence
Carucci has adopted a new technique, capillary
liquid chromatography coupled with tandem mass
spectrometry, as an alternative. This combined
approach facilitates high-throughput analysis of
the protein content of a cell or tissue, without the
possibly limiting step of electrophoresis.
Carucci also made the point that any laboratory
wishing to get heavily involved in proteomics or
microarray analysis will need specialised bioinfor-
matics tools to analyse the data efﬁciently. His
laboratory uses an in-house relational database to
link information from the malaria genome, micro-
array experiments and proteomics experiments.
David Roos, (Pennsylvania, USA) in his paper
‘Mining the Plasmodium genome database to deﬁne
organellar function’ discussed how Toxoplasma
gondii can be used as a useful model for molecular
studies of other Apicomplexan parasites. Studies in
Toxoplasma have elucidated the function of the
apicoplast, which up until recently had remained a
mystery.
The apicoplast is an organelle, unique to apicom-
plexan parasites, which is associated with the apical
complex of the cell. It has such signiﬁcant similarity
to a plant chloroplast that it is believed to have
arisen from a secondary endosymbiotic event of an
ancient ancestor of modern plants. The apicoplast
Meeting Review 259
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keeping genes, yet it has since been validated as a
prophylactic drug target. By data mining the
P. falciparum genome sequence, Roos and his
colleagues were able to identify a number of genes
that were predicted to be localised in the apicoplast;
this was achieved by identifying genes exhibiting
similarity to chloroplast-encoded genes in plants, or
displayed other ‘‘plant-like’’ characterisics. The
Roos group were then able to test if the protein
products from these, and other genes targeted to the
apicoplast are by using a range of GFP fusion
constructs in Toxoplasma. To date 150 nuclear-
encoded plastid genes have been identiﬁed, giving
an almost complete picture of plastid metabolism.
This work has demonstrated how well designed
bioinformatic studies, validated by ‘‘wet lab’’ experi-
mentation, can be a powerful and efﬁcient approach
to functional studies. To facilitate this, the Roos
lab has established a web-accessible Plasmodium
genome database [6], PlasmoDB (www.plasmodb.
org).
The phenomenon of RNA interference (RNAi)
has provided a very useful tool for functional
studies of diploid organisms, such as Drosophila [5]
and C. elegans [4]. In her presentation ‘Genetic
interference by double-stranded RNA in Trypano-
soma brucei’, Elisabetta Ullu (Yale, USA) demon-
strated how it has also been put to use in the
T. brucei parasite. RNAi uses double-stranded
RNA molecules to down-regulate levels of
mRNA in cells. This technique has a number of
advantages over traditional knockouts, as it avoids
the need to transfect organisms twice to knock out
both copies of a gene. Also, mutant phenotypes
can be rescued using regulated promoters to
mediate the degree of interference.
The mechanisms behind gene regulation by
RNAi are not well understood; however Ullu and
her colleagues have come a long way towards
elucidating them. They have identiﬁed siRNA
(small interfering RNA) species in Trypanosomes
that are believed to interact with polyribosomes,
thus preventing translation. A high proportion of
these siRNAs are derived from the retrotransposon-
like repeat sequences INGI and SLACS, suggesting
that RNAi may play a role in the regulation of
these elements.
The RNAi data for T. brucei are encouraging,
but questions remain. Why, for example, is RNAi
proving so hard to demonstrate in the related
kinetoplastid Leishmania? Time will no doubt tell,
but irrespective of this, the observation of RNAi in
parasites underlines that they are not only of
interest on account of their medical importance,
but can frequently provide useful experimental
model systems for investigating fundamental biolo-
gical phenomena. This point was also exempliﬁed
by Ken Stuart in his presentation entitled ‘The
editing complex of Trypanosoma brucei’.
In his presentation ‘Genetic analysis of phenotype
in T. brucei: a classical approach to potentially
complex traits’, Andy Tait (Glasgow, UK), spoke
about the relevance of genetic studies in the post-
genomic era. While genetic analysis is typically not
a high throughput technique for functional ana-
lyses, it has its advantages in that the work is
biologically driven with a deﬁned phenotype that
usually can be chosen for its scientiﬁc relevance,
such as drug resistance or reduced infectivity;
complex phenotypes are notoriously difﬁcult to
study by gene knockouts or RNAi.
Tait and his colleagues now have a genetic map
of Trypanosoma brucei mini-satellite and micro-
satellite markers at a resolution of 10 cM on
chromosomes I and II, and a partial map of
chromosome IV. They also have 140 AFLP
markers, giving a total map covering 1/3 of the
genome.
The Tait group intends to complete this map over
the next few years. Stocks of T. brucei have been
identiﬁed that differ in their drug sensitivity, human
infectivity and virulence, and these parental stocks
are being crossed to build up a series of progeny
panels. Linkage analysis is to be used to determine
the genetic bases underlying these important phe-
notypes.
In his presentation ‘Demonstration of the ortholo-
gous nature of the genomes of Plasmodium berghei
and Plasmodium falciparum: exploitation to under-
stand parasite interactions with both its host and
vector’ Andrew Waters (Leiden, The Netherlands)
spoke about how comparative genomics is starting
to aid our understanding of the structure and
content of malaria genomes. The genomes of
Plasmodium spp have been shown to be highly
syntenic [2,1]. Synteny is a measure of genetic
conservation, which may refer to entire chromo-
somes or simply neighbouring segments of DNA. It
does not, as is commonly thought, simply measure
gene order.
Prior to genome sequencing, synteny was mea-
sured by hybridising DNA probes to pulsed ﬁeld gel
electrophoresis (PFGE)- separated chromosomes. It
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syntenic, with almost all probes hybridising to
equivalent chromosomes in all species analysed.
There is also signiﬁcant synteny between rodent
malarias and the human parasite, P. falciparum.
Waters demonstrated how synteny on a smaller
scale (i.e. conservation over small genetic distances)
can aid the annotation and analysis of genome
sequence data.
Waters and his collaborators have fully
sequenced a YAC clone containing DNA from the
rodent malaria species Plasmodium berghei. The
sequence obtained from this clone has been care-
fully analysed and the primary transcipt RNA
splicing characteristics of the 6 predicted genes
annotated. The P. berghei YAC is highly syntenic
with a contig sequenced and assembled by The
Institute of Genomic Research (TIGR, Washington)
from chromosome 10 of P. falciparum. When the
two sequences are compared, it is clear that the
coding regions are considerably more conserved
than non-coding regions, hence it is possible to
directly compare the predicted genes and splicing
patterns between the two species.
Importantly, this work demonstrates that given a
well-studied sequence from one Plasmodium species,
conserved DNA synteny will enable us to identify
structural components and coding regions in other
species. Variations from this ‘rule’ will serve as ﬂags
for areas containing potentially interesting biologi-
cal features (e.g. host restriction). Also, even two
syntenic, but otherwise uncharacterised sequences
could give clues to the location and structure of
genes within both of them, due to the inherent
conservation between the coding regions.
In his presentation ‘Metabolic analysis in trypano-
somes and malaria’, Alan Fairlamb (Dundee, UK)
concentrated on the analysis of metabolic pathways
in parasitic organisms. Such analysis is critical for
the identiﬁcation of potential drug targets. In
theory, the availability of a completely annotated
genome sequence should provide investigators with
a complete metabolome that should in turn provide
a wide array of possible drug targets. However,
Fairlamb went on to explain that the analysis of
such a complex data set requires well-designed and
well-curated metabolism databases.
As an example, Fairlamb discussed the poly-
amine biosynthesis pathway in the kinetoplastids
Leishmania and Trypanosoma; in these protozoan
parasites, the enzyme trypanothione reductase is
present, ‘‘replacing’’ the glutathione reductase
found in the mammalian pathway [3].
This difference results in a unique metabolite,
trypanothione (N1, N8-bis(glutathionyl)-spermidine),
which has taken on many of the protective and anti-
oxidant functions normally ascribed to glutathione
in mammalian cells. Inhibitor studies have validated
the parasite pathway as a possible drug target.
However in some public metabolic pathway data-
bases, this novel pathway is not represented, despite
the breadth of knowledge available.
This is an unsatisfactory state of affairs, as
components of pathways that are unique to, or
different in, medically relevant organisms are more
than likely to be candidate drug targets. Intensiﬁed
dialogue between the research communities, and
those curating the public databases, is a priority for
all scientists involved in the ﬁeld of parasite
functional genomics.
Chris Newbold (Oxford, UK) closed by thanking
everyone for their contribution to the discussions,
and the Royal Society for hosting the meeting. In
keeping with the number of different organisms that
were the subject of the talks over the two days, he
suggested that perhaps one of the most important
messages from the meeting was that a great deal of
information would come from comparative geno-
mics. With so many genomes being sequenced now
by centres around the world, parasitic protozoa
offer an exciting opportunity to understand genome
evolution, possibly more so than in any other area
of eukaryotic biology. It was also very important
that the communities take on board the concept of
pre-competitive research, particularly if the huge
quantity of sequencing, expression and proteomics
data, to cite but three examples, were to be used to
their full potential.
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